Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace E Asuelime

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Molecular Cell Biology|February 29, 2012
A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicineGrace E Asuelime, Yanhong Shi
Frontiers in Pediatrics|June 6, 2018
Congenital Perirectal Dermoid Cyst: A Rare Cause of Complex, Recurrent Pediatric Fistula-in-anoWesley E Barry, Grace E Asuelime, Shengmei Zhou, et al.
The Journal of Surgical Research|April 17, 2024
Differential RNA Expression Between Metastatic and Primary Neuroblastoma CellsWilliam G Lee, Grace E Asuelime, Matthew B T Asuelime-Smith, et al.
Cancer Research Communications|March 2, 2023
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen SelectivityTalar Tokatlian, Grace E Asuelime, Martin S Naradikian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary NeuroblastomaWesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.
Molecular Immunology|October 5, 2020
Engineered T cells directed at tumors with defined allelic lossAgnes E Hamburger, Breanna DiAndreth, Jiajia Cui, et al.
Scientific Reports|November 14, 2023
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastomaDanny Lascano, Michael J Zobel, William G Lee, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cellsTalar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Molecular Immunology|August 10, 2020
Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigenHan Xu, Agnes E Hamburger, Jee-Young Mock, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Molecular Cell Biology|February 29, 2012
A case of cellular alchemy: lineage reprogramming and its potential in regenerative medicineGrace E Asuelime, Yanhong Shi
Frontiers in Pediatrics|June 6, 2018
Congenital Perirectal Dermoid Cyst: A Rare Cause of Complex, Recurrent Pediatric Fistula-in-anoWesley E Barry, Grace E Asuelime, Shengmei Zhou, et al.
The Journal of Surgical Research|April 17, 2024
Differential RNA Expression Between Metastatic and Primary Neuroblastoma CellsWilliam G Lee, Grace E Asuelime, Matthew B T Asuelime-Smith, et al.
Cancer Research Communications|March 2, 2023
Chimeric Antigen Receptors Directed at Mutant KRAS Exhibit an Inverse Relationship Between Functional Potency and Neoantigen SelectivityTalar Tokatlian, Grace E Asuelime, Martin S Naradikian, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2018
Activated Natural Killer Cells in Combination with Anti-GD2 Antibody Dinutuximab Improve Survival of Mice after Surgical Resection of Primary NeuroblastomaWesley E Barry, Jeremy R Jackson, Grace E Asuelime, et al.
Molecular Immunology|October 5, 2020
Engineered T cells directed at tumors with defined allelic lossAgnes E Hamburger, Breanna DiAndreth, Jiajia Cui, et al.
Scientific Reports|November 14, 2023
Anti-CCL2 antibody combined with etoposide prolongs survival in a minimal residual disease mouse model of neuroblastomaDanny Lascano, Michael J Zobel, William G Lee, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cellsTalar Tokatlian, Grace E Asuelime, Jee-Young Mock, et al.
Molecular Immunology|August 10, 2020
Structure-function relationships of chimeric antigen receptors in acute T cell responses to antigenHan Xu, Agnes E Hamburger, Jee-Young Mock, et al.
Pageof 1